Neuroscientific Biopharmaceuticals Ltd has released a press release.
2023 Annual Report and Appendix 4E
Filed with ASX ·
6ix hasn’t read this filing yet.
Neuroscientific Biopharmaceuticals Ltd. on 6ix
Story so far
Earlier from Neuroscientific Biopharmaceuticals
- Positive treatment effect in MS animal study
- R&D Tax Incentive Refund Received
- NSB files new patent
- Appointment of Interim CEO
- Investor Update Presentation
Later from Neuroscientific Biopharmaceuticals
- Appointment of CEO
- Resignation of CEO
- NSB Receives A$2.2M Research & Development Tax Refund
- Appointment of Executive Director & FDA Pre-Ind Meeting
- 2024 Annual Report & Appendix 4E
Follow Neuroscientific Biopharmaceuticals into a list and get an email when it puts out news.
Follow Neuroscientific Biopharmaceuticals